The rise in the prevalence of cardiovascular diseases and peripheral vascular diseases, adaptation to a sedentary lifestyle, better healthcare facilities are key factors contributing to increase of the PTA balloon market during the last few years. According to the current market analysis the global PTA balloon Catheter market is still expected to double in the next coming years.
Qmedics sparing no expense or efforts, took on the courage & challenge to meet the high regulatory requirements had a lot of patience during the difficult COVID time where the Notified body approvals took forever.
We can proudly announce the CE certification of the new PTA balloon family portfolio: Manatee 6F-Naga 5F & Nova 4F
The Qmedics PTA balloon family has a wide spread of sizes that treat more lesions and locations.
The new portfolio is totally manufactured at the Qmedics facility- from raw material to the final sterilized product. Qmedics controls each and all processes of the manufacturing and has no external processes.
Treatment of the Femoro-Popliteal district with the innovative Exist NiTi Stent (QMEDICS) type Flex & Pull: the HORIZON clinical trial. Marone E.M.1, Rinaldi …
I am very pleased that Qmedics AG has been able to achieve the GMP certification. A GMP certification in general is granted to …
The use of cyanoacrylates, used for embolization for a long period of time, has decreased in the last decades, they are currently still …
In 2016 the Board of Directors decided to sell the sister company of Qmedics, who was at the same time the biggest customer …
Our travel did start with a strike of the taxi drivers, a delay in our shipment of workshop material- but as a team …
With the organization of workshops the professionals get to understand the two stent types “ Pull & Flex”. The first workshop “Endovascular treatments …
Copyright © 2023 Qmedics AG. All rights reserved.
